Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NASDAQ: CRBP · IEX Real-Time Price · USD

39.24

+2.71 (7.42%)

At close: Apr 19, 2024, 4:00 PM

37.99

-1.25 (-3.19%)

After-hours: Apr 19, 2024, 6:16 PM EDT

CRBP Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0	0	0.88	3.94	36.14	4.82	2.44	1.91	0.65	0	Upgrade
Revenue Growth (YoY)	-	-	-77.61%	-89.11%	649.51%	97.62%	27.66%	194.80%	-	-	Upgrade
Gross Profit	0	0	0.88	3.94	36.14	4.82	2.44	1.91	0.65	0	Upgrade
Selling, General & Admin	13.91	18.7	20.43	28.48	23.64	12.96	8.96	6.46	3.61	1.39	Upgrade
Research & Development	31.17	16.14	36.45	98.27	89.6	48.61	26.04	15.44	5.89	1.26	Upgrade
Other Operating Expenses	0	5	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	45.08	39.84	56.87	126.75	113.25	61.57	35	21.9	9.5	2.65	Upgrade
Operating Income	-45.08	-39.84	-55.99	-122.81	-77.1	-56.75	-32.56	-19.99	-8.85	-2.65	Upgrade
Interest Expense / Income	2.92	2.13	1.83	1.03	-1.23	0	0	0	0	0.02	Upgrade
Other Expense / Income	-3.4	0.38	-12.18	-12.57	-4.42	-1.08	-0.14	0.01	-0	-0.13	Upgrade
Pretax Income	-44.6	-42.35	-45.64	-111.27	-71.45	-55.67	-32.42	-20	-8.85	-2.54	Upgrade
Net Income	-44.6	-42.35	-45.64	-111.27	-71.45	-55.67	-32.42	-20	-8.85	-2.54	Upgrade
Shares Outstanding (Basic)	4	4	4	3	2	2	2	1	1	1	Upgrade
Shares Outstanding (Diluted)	4	4	4	3	2	2	2	1	1	1	Upgrade
Shares Change	3.76%	1.85%	57.23%	22.28%	12.10%	13.60%	21.97%	31.22%	55.51%	189.45%	Upgrade
EPS (Basic)	-10.31	-10.15	-11.15	-42.60	-33.60	-29.40	-19.50	-14.70	-8.40	-3.90	Upgrade
EPS (Diluted)	-10.31	-10.15	-11.15	-42.60	-33.60	-29.40	-19.50	-14.70	-8.40	-3.90	Upgrade
Free Cash Flow	-36.1	-37.55	-48.21	-100.17	-48.46	-32.37	-28.5	-13.92	-4.74	-2.43	Upgrade
Free Cash Flow Per Share	-8.34	-9.00	-11.77	-38.46	-22.75	-17.04	-17.04	-10.15	-4.54	-3.61	Upgrade
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-	-	-6350.09%	-3119.20%	-213.33%	-1176.78%	-1334.43%	-1045.56%	-1365.51%	-	Upgrade
Profit Margin	-	-	-5176.38%	-2826.08%	-197.69%	-1154.48%	-1328.65%	-1046.27%	-1365.05%	-	Upgrade
Free Cash Flow Margin	-	-	-5468.27%	-2544.18%	-134.09%	-671.21%	-1168.11%	-728.48%	-730.88%	-	Upgrade
EBITDA	-41.04	-39.45	-42.17	-108.55	-71.45	-55.18	-32.17	-19.91	-8.81	-2.51	Upgrade
EBITDA Margin	-	-	-4782.86%	-2756.93%	-197.69%	-1144.24%	-1318.17%	-1041.68%	-1358.27%	-	Upgrade
Depreciation & Amortization	0.64	0.76	1.64	1.69	1.23	0.49	0.26	0.09	0.04	0.01	Upgrade
EBIT	-41.68	-40.21	-43.81	-110.24	-72.68	-55.67	-32.42	-20	-8.85	-2.52	Upgrade
EBIT Margin	-	-	-4968.78%	-2799.96%	-201.09%	-1154.48%	-1328.65%	-1046.27%	-1365.05%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).